Lung Cancer
Conditions
Brief summary
the aim of this study is to measure brain metabolism in patients with lung cancer.FDG uptake in the brain in patients with malignant tumors will be compared to the amount of tracer activity found in patients who have benign pulmonary process. if differences between the brain uptake of FDG in the two groups will be found, further assessment will be performed in order to evaluate if such differences could be attributed and specifically localized to the brain regions innervated by the vagus
Interventions
Sponsors
Study design
Eligibility
Inclusion criteria
* patients with SPN referred for routine whole body FDG-PET imaging * patients with NSCLC and patients with no evidence of lung cancer on further follow up
Exclusion criteria
* patients with a clinical history of vagotomy, abdominal surgery. brain tumor, brain trauma or CVA. or those with a systemic inflammatory disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the impact of the imaging modality on patients management | — |
Secondary
| Measure | Time frame |
|---|---|
| the impact of the imaging modality on patients management | — |
Countries
Israel